Mechanism of human polymorphonuclear leukocyte adhesion to serum-treated corneocytes.
The accumulation of polymorphonuclear leukocytes (PMN) beneath the stratum corneum is a characteristic histopathologic finding in various aseptic pustular dermatoses. To elucidate the pathomechanism involved in this phenomenon, we investigated whether PMN also attach to a sheet of corneocytes in vitro. A 1-cm2 corneocyte sheet was attached to a sterile glass slide with double adhesive tape used for skin graft surgery before incubating with human serum. The PMN suspension then was applied to the sheet. Attached cells were stained with May-Grunwald-Giemsa and counted with a computer image analyzer. We quantitatively assessed PMN adhesion to the serum-treated corneocyte sheets, which was mediated by activation of the alternative complement pathway. Addition of either anti-CD18 or anti-CD11b antibody to the assay system resulted in a marked reduction of PMN adhesion. We also demonstrated immunohistochemically that iC3b was formed on the serum-treated corneocytes. These findings suggest that PMN attach to serum-treated corneocytes through an interaction of CR3 expressed on PMN with iC3b-coated corneocytes. In addition, we found that this adhesion was enhanced by activation of PMN with phorbol myristate acetate. From these results, we speculate that complement activation by corneocytes occurs in the cutaneous lesions of aseptic pustular dermatoses and that PMN can be stimulated by the interaction with iC3b-opsonized corneocytes as well as by chemotaxins, leading to damage of the surrounding epidermal keratinocytes.
Terui
T
T
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan.
Zhen
Y X
YX
Kato
T
T
Tagami
H
H
D001790:Blood Physiological Phenomena; D002448:Cell Adhesion / Q000187:drug effects / Q000502:physiology; D003167:Complement Activation; D003180:Complement C3b Inactivator Proteins / Q000494:pharmacology; D006801:Humans; D009504:Neutrophils / Q000166:cytology*; D012867:Skin / Q000166:cytology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D003180:Complement C3b Inactivator Proteins; D013755:Tetradecanoylphorbol Acetate